Anti-AIP antibodies are used in the immunodetection of the protein aryl hydrocarbon receptor interacting protein. In humans, the canonical protein has a reported length of 330 amino acid residues and a mass of 37.7 kDa. Its subcellular localization is in the cytoplasm. It is widely expressed across many tissue types. AIP is believed to play a positive role in AHR-mediated (aromatic hydrocarbon receptor) signaling, possibly by influencing its receptivity for ligand and/or its nuclear targeting; Cellular negative regulator of the hepatitis B virus (HBV) X protein. The AIP gene has been associated with the disease, Pituitary adenoma. Synonyms for this target antigen include FKBP16, FKBP37, PITA1, SMTPHN, XAP-2, XAP2, AH receptor-interacting protein, and ARA9. AIP gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of AIP antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.